OCP Aims for Full Control of Emaphos and Strengthens Its Position in Specialty Phosphates
Moroccan Group Plans Acquisition of Two Stakeholders in Emaphos for Enhanced Industrial Strategy
The Moroccan group OCP is set to acquire the stakes of the German company Chemische Fabrik Budenheim and Belgium’s Prayon in Emaphos, a producer of purified phosphoric acid based in Jorf Lasfar. The deal, anticipated to be finalized by early 2027 pending necessary approvals, aligns with OCP’s strategy for upgrading its industrial capabilities.
OCP is taking a significant step in expanding its high-value-added activities. The group has announced its intention to purchase the shares held by Chemische Fabrik Budenheim KG and Prayon SA in Euro Maroc Phosphore (Emaphos), its joint venture focused on producing purified phosphoric acid.
Once the operation is complete, managed by OCP Specialty Products & Solutions (SPS), a wholly-owned subsidiary of OCP, Emaphos will become a fully controlled subsidiary of the Moroccan group. This transaction is subject to customary closing conditions and applicable regulatory approvals, with completion expected by early 2027.
Founded in 1996 in Jorf Lasfar, Emaphos has specialized in producing purified phosphoric acid, a product designed for markets with high technical requirements. Its applications include specialty fertilizers, food production, pharmaceuticals, and certain uses related to energy transition and batteries.
Originally established with a production capacity of 140,000 tons per year, Emaphos has increased its capacity to approximately 300,000 tons in 2023. This growth has cemented the unit’s role in the industrial valorization of Moroccan phosphate.
Accelerating Industrial Integration
Beyond changing its shareholder structure, the operation aims to strengthen Emaphos’s operational integration within the OCP ecosystem. The group seeks to bolster its position in specialty phosphates, a segment that enables diversification beyond traditional fertilizer markets.
The goal is to better align industrial capabilities, product development, and access to end markets. In food and pharmaceutical applications, for example, purification must meet specific quality and compliance requirements. Additionally, opportunities linked to energy transition open up pathways for diversification, although their potential will depend on demand trends and industrial applications.
OCP emphasizes that Prayon and Chemische Fabrik Budenheim will remain strategic trade partners for Emaphos and will maintain their existing supply relationships. Therefore, the change in control does not imply a break in the established industrial and commercial relationships since the joint venture’s inception.
A New Phase in Upgrading Quality
This acquisition is part of a broader direction for OCP: to enhance the value derived from the phosphate resource through transformation and the development of specialized products. Full ownership of Emaphos would provide OCP with strengthened capital control over an already established industrial tool, eliminating the need for a new production platform.
However, the actual impact of this acquisition will depend on its successful completion, integration methods, and the ability to cultivate markets for purified phosphoric acid. For OCP, the challenge is to translate a solid industrial position into a sustainable growth lever in markets where product quality, process control, and supply reliability are critical.
